GranuFlo® Recall Class I
On March 29, 2012, the U.S. Food and Drug Administration (FDA) issued a recall of kidney dialysis products NaturaLyte® and GranuFlo®. These products were recalled after studies found their use could lead to high levels of serum bicarbonate in patients, which can cause cause a condition called metabolic alkalosis—a risk factor for cardiac arrhythmia and other serious health problems.
If you or someone you love had kidney dialysis with GranuFlo or NaturaLyte products and suffered cardiac arrhythmia, low blood pressure, or other complications, you may be eligible to file a claim for compensation for medical bills and other expenses. Call the GranuFlo injury lawyers at Ferrer, Poirot & Wansbrough at (800) 210-8503 or fill out a free initial consultation form.
Types of FDA Recalls
The FDA’s recall of NaturaLyte and GranuFlo was categorized as Class I. The FDA divides product recalls into three categories:
- Class I Recall
These recalls are for products that are dangerous or defective and could cause serious and permanent health problems or death.
- Class II Recall
These recalls are for products that are dangerous but may only cause temporary health problems or non-life-threatening complications.
- Class III Recall
These recalls are for products that are defective or mislabeled, but aren’t dangerous to the public.
Hospitals or treatment facilities that used NaturaLyte or GranuFlo after the recall was issued may be considered negligent. At Ferrer, Poirot &Wansbrough, it’s our job to hold negligent healthcare providers and the manufacturers of dangerous products accountable for injuries and illnesses caused by their carelessness.
We Want to Help You
The GranuFlo heart attack lawyers at Ferrer, Poirot & Wansbrough are dedicated to protecting the rights of victims like you against big pharmaceutical companies and their legal teams. We’re here to fight for the money you deserve. Don’t suffer because you were exposed to a medical product that was supposed to help. Contact us today.
GranuFlo® and NaturaLyte® are registered trademarks of Fresenius Medical Care North America and are used here only for the purpose of identifying the product in question.
This law firm is not associated with, sponsored by, or affiliated with the U.S. Food and Drug Administration or Fresenius Medical Care.